BeiGene Switzerland GmbH

BeiGene Switzerland GmbH is a global, commercial-stage research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapies. BeiGene Switzerland GmbH is advancing a pipeline consisting of novel oral small molecules and cancer monoclonal antibodies. BeiGene Switzerland GmbH is also committed to creating combination solutions aimed at making a meaningful and lasting impact on cancer patients.